# Compass Therapeutics, Inc.: Form 8-K, filed Jan 9, 2024

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: 8-K
- Filed: 2024-01-09
- Accepted by EDGAR: Jan 9, 2024, 17:30 ET
- Period: 2024-01-08
- Accession: 0001171843-24-000164
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000117184324000164/f8k_010924.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000117184324000164/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000117184324000164/f8k_010924.htm

Filed Jan 9, 2024.
Source: SEC EDGAR, the filing index for accession 0001171843-24-000164. Last ingested by Listed: Nov 10, 2026, 16:45 ET. No prices; not investment advice.
